Direxion Daily S&P Biotech Bull 3X Shares LABU
Set alert
247.22 USD -9.74 -3.79%
At close · Oct 30
247.00 -0.22 -0.09%
After hours · Oct 30, 7:29 PM ET
239.28 Day range 264.75
115.29 52-week range 341.55
- YTD
- +55.10%
- 1 year
- +92.76%
- Open
- 251.50
- Prev close
- 256.96
- Mkt cap
- 1.37B
- Vol
- 303.07K
- Avg vol
- 400.51K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 239.28
- High
- 264.75
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 262.35
- 200-d avg
- 216.17
- 1y target
- 0.00
3M chart
Signals (12)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
| SMA: Bearish | Jul 31, 2026 | 3 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 262.35
- 200-day average
- 216.17
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About Direxion Daily S&P Biotech Bull 3X Shares
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on LABU — it syncs with the Stock Master app.